We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Compugen Discloses New Results Supporting CGEN-15052

News   Sep 17, 2015

 
Compugen Discloses New Results Supporting CGEN-15052
 
 
 

RELATED ARTICLES

Immune Cells Put Into Gear by Molecular "Clutch"

News

Proteins that drive activation of our immune response, by acting as a ‘clutch’ to move clusters of proteins within cells, have been identified. This could open opportunities to design immune cells to combat specific problems.

READ MORE

Targeting Enzyme “Bottleneck” Reveals Novel Anticancer Drug Strategy

News

The enzyme ribonucleotide reductase is a bottleneck for cancer cell growth. Scientists have now identified a way of targeting ribonucleotide reductase that may avoid the toxicity of previous approaches, informing focused drug discovery efforts.

READ MORE

Compound Created to Block Therapeutic Target in Blood Cancer

News

Researchers have discovered a hyperactive cell signal that contributes to tumor growth in an aggressive blood cancer. The team has also developed an experimental therapeutic "UNC3810A" to block the signal and slow tumor growth.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE